Although other clinical outcomes appeared to favor enzalutamide, the differences did not reach statistical significance.
← all excerpts
Comparative Effectiveness of Management Strategies for Stage IV Prostate Cancer: A Narrative Review.
1
—
—
Although other clinical outcomes appeared to favor enzalutamide, the differences did not reach statistical significance.